DNA - Ginkgo Bioworks Holdings, Inc.
6.5
-0.340 -5.231%
Share volume: 935,860
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.19%
PREVIOUS CLOSE
CHG
CHG%
$6.84
-0.34
-0.05%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 02-25-2025 | 05-06-2025 | 11-06-2025 | 02-26-2026 | |
| Assets | |||||
| Total Assets | 1.377 B | 1.293 B | 1.189 B | 1.120 B | |
| Current Assets | 602.744 M | 564.534 M | 506.082 M | 471.838 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 204.502 M | 350.797 M | 255.418 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 561.572 M | 312.420 M | 111.065 M | 167.202 M | |
| Total Non-current Assets | 48.704 M | 32.173 M | 30.175 M | 15.066 M | |
| Property Plant Equipment | 203.720 M | 197.828 M | 176.579 M | 167.783 M | |
| Other Assets | 570.985 M | 531.101 M | 506.504 M | 480.075 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||
| Total Liabilities and shareholders’ equity | 1.377 B | 1.293 B | 1.189 B | 1.120 B | |
| Total liabilities | 661.391 M | 646.036 M | 629.382 M | 611.106 M | |
| Total current liabilities | 107.266 M | 115.667 M | 115.281 M | 95.970 M | |
| Accounts Payable | 14.169 M | 11.267 M | 10.704 M | 10.566 M | |
| Other liabilities | 455.342 M | 449.991 M | 440.029 M | 439.954 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 455.342 M | 449.991 M | 440.029 M | 439.954 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 716.058 M | 647.427 M | 559.783 M | 508.590 M | |
| Common stock | 6.555 B | 6.577 B | 6.627 B | 6.657 B | |
| Retained earnings | -5.838 B | -5.929 B | -6.070 B | -6.150 B |